- San Diego State University (B.A., 1982, magna cum laude, with distinction in the major)
- Georgetown University Law Center
- District of Columbia
- United States District Court for the District of Columbia
- Just weeks before jury selection, U.S District Court for the Eastern District of New York rules that testimony from plaintiff''s purported regulatory and warnings expert be excluded in its entirety.
Hogan v. Novartis Pharm. Corp., 1:06-cv-00260-BMC-RER (E.D.N.Y. May 3, 2011)
Julie A. Blum joined Hollingsworth LLP in 1990 following a clerkship with the Honorable Mildred M. Edwards of the District of Columbia Superior Court. Her practice specializes in defending corporate clients in complex mass tort products liability litigation in state and federal proceedings. She is experienced in mass tort claims, including serial litigation, multidistrict litigation, and class action litigation, and has assisted in the oversight and management of large scale litigation involving a wide range of pharmaceutical products and compounds. In addition, she has managed pre-trial fact discovery in products liability and mass tort litigation for more than twenty years. She also has experience in commercial contract litigation.
Ms. Blum has spoken on defense strategies before national pharmaceutical conference attendees, and was a regular contributor to the Products Liability Law & Strategy reporter, published by Law Journal Newsletters.
Ms. Blum serves as a member of the Board of Directors of the Tuberous Sclerosis Complex Alliance and is a past member of the Board of Directors of the Tuberous Sclerosis Complex Endowment Fund. She also serves on the Government Relations Committee of the Tuberous Sclerosis Complex Alliance and is a past co-chair of that committee.
- Practice Tip